Altimmune Inc
For the period ended Dec 31, 2023. Filed Mar 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 27, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
9. Warrants
- Warrants
The following common stock warrants were outstanding at December 31, 2023:
| · · · · · · · · · | |||||
|---|---|---|---|---|---|
| · · Number of · · · · · · · | |||||
| · · Common · · Per Share · · · · | |||||
| · · Stock · · Exercise · · · · | |||||
| · · Warrants · · Price · · Issuance Date · · Expiration Date | |||||
| Issued with common units in the 2019 Registered Direct Offering | 50,000 | | $3.21 | March 12, 2019 | March 12, 2024 |
| Total | 50,000 | | |||
The following common stock warrants were outstanding at December 31, 2022:
| · · · · · · · · · | ||||||
|---|---|---|---|---|---|---|
| · · Number of · · · · · · · | ||||||
| · · Common · · Per Share · · · · | ||||||
| · · Stock · · Exercise · · · · | ||||||
| · · Warrants · · Price · · Issuance Date · · Expiration Date | ||||||
| Issued with common units in the 2018 Unit Offering | 3,300 | | $2.7568 | October 2, 2018 | October 2, 2023 | |
| Issued with common units in the 2018 Registered Direct Offering | 92,300 | | $5.40 | October 10, 2018 | October 10, 2023 | |
| Issued with common units in the 2019 Registered Direct Offering | 50,000 | | $3.21 | March 12, 2019 | March 12, 2024 | |
| Issued with common units in the 2020 Public Offering (see Note 8) | | 869,566 | | $0.0001 | July 16, 2020 | — |
| Total | 1,015,166 | | ||||
On October 18, 2023, warrant holders exercised the remaining 869,566 Pre-Funded Warrants in a net cashless exercise and were issued 869,530 shares of common stock (see Note 8 Common Stock). In addition, in October 2023,95,600 various other warrants with a weighted-average exercise price of $5.31 expired unexercised. On March 5, 2024, the remaining 50,000 warrants with an exercise price of $3.21 were fully exercised, resulting in the issuance of 50,000 shares of common stock.
A summary of warrant activity is as follows:
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| | | | | | | | Weighted-Average |
| · · · Weighted · · Remaining | |||||||
| | | Number of | | | Average | | Contractual Term |
| | | Warrants | | | Exercise Price | | (Years) |
| Warrants outstanding, December 31, 2022 | 1,015,166 | | | | | ||
| Exercised (see Note 8) | | (869,566) | | | | | |
| Expired | (95,600) | | | | | ||
| Warrants outstanding, December 31, 2023 | 50,000 | $3.21 | | 0.2 | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.